Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionAuxier Asset Management
Latest Disclosed Ownership21,851 shares
Latest Disclosed Value $ 1,325,275
Auxier Asset Management reports 0.22% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 14, 2026 - Auxier Asset Management filed a 13F-HR form disclosing ownership of 21,851 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,145,429 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 21,900 shares of Bristol-Myers Squibb Company. This represents a change in shares of -0.22% during the quarter. The current value of the position is $1,036,393 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F Bristol Myers Squibb COM 110122108 21,851 -49 -0.22 1,325 12.19 0.1903
2026-02-17 2025-12-31 13F Bristol Myers Squibb COM 110122108 21,900 -1,840 -7.75 1,181 10.37 0.1661
2025-11-19 2025-09-30 13F Bristol Myers Squibb COM 110122108 23,740 130 0.55 1,071 -2.01 0.1501
2025-08-15 2025-06-30 13F Bristol Myers Squibb COM 110122108 23,610 -92 -0.39 1,093 -24.43 0.1605
2025-05-14 2025-03-31 13F Bristol Myers Squibb COM 110122108 23,702 -645 -2.65 1,446 4.94 0.2155
2025-02-19 2024-12-31 13F Bristol Myers Squibb COM 110122108 24,347 -150 -0.61 1,377 8.68 0.2135
2024-11-14 2024-09-30 13F Bristol Myers Squibb COM 110122108 24,497 -49 -0.20 1,267 24.34 0.1873
2024-08-13 2024-06-30 13F Bristol Myers Squibb COM 110122108 24,546 -624 -2.48 1,019 -25.29 0.1614
2024-05-08 2024-03-31 13F Bristol Myers Squibb COM 110122108 25,170 -1,604 -5.99 1,365 -0.66 0.2076
2024-02-22 2023-12-31 13F Bristol Myers Squibb COM 110122108 26,774 -2,049 -7.11 1,374 -17.88 0.2223
2023-11-21 2023-09-30 13F Bristol Myers Squibb COM 110122108 28,823 -50 -0.17 1,673 -9.43 0.2854
2023-08-17 2023-06-30 13F Bristol Myers Squibb COM 110122108 28,873 -74 -0.26 1,846 -7.98 0.3063
2023-05-15 2023-03-31 13F Bristol Myers Squibb COM 110122108 28,947 -300 -1.03 2,006 -4.66 0.3463
2023-02-17 2022-12-31 13F Bristol Myers Squibb COM 110122108 29,247 0 0.00 2,104 1.20 0.3632
2022-11-15 2022-09-30 13F Bristol Myers Squibb COM 110122108 29,247 -849 -2.82 2,079 -10.27 0.4006
2022-08-11 2022-06-30 13F Bristol Myers Squibb COM 110122108 30,096 -999 -3.21 2,317 2.03 0.4138
2022-05-17 2022-03-31 13F Bristol Myers Squibb COM 110122108 31,095 75 0.24 2,271 17.43 0.3601
2022-03-01 2021-12-31 13F Bristol Myers Squibb COM 110122108 31,020 1 0.00 1,934 5.40 0.3003
2021-11-18 2021-09-30 13F Bristol Myers Squibb COM 110122108 31,019 -49 -0.16 1,835 -11.61 0.3105
2021-08-18 2021-06-30 13F Bristol Myers Squibb COM 110122108 31,068 -539 -1.71 2,076 4.06 0.3441
2021-05-17 2021-03-31 13F Bristol Myers Squibb COM 110122108 31,607 -402 -1.26 1,995 0.45 0.3431
2021-03-05 2020-12-31 13F Bristol Myers Squibb COM 110122108 32,009 14,570 83.55 1,986 88.96 0.3686
2021-03-05 2020-09-30 13F Bristol Myers Squibb COM 110122108 17,439 1,233 7.61 1,051 10.28 0.2198
2020-08-20 2020-06-30 13F Bristol Myers Squibb COM 110122108 16,206 9,181 130.69 953 143.11 0.2102
2020-05-15 2020-03-31 13F Bristol Myers Squibb COM 110122108 7,025 645 10.11 392 -4.39 0.0979
2020-02-21 2019-12-31 13F Bristol Myers Squibb COM 110122108 6,380 311 5.12 410 33.12 0.0763
2019-11-15 2019-09-30 13F Bristol Myers Squibb COM 110122108 6,069 150 2.53 308 14.93 0.0619
2019-08-15 2019-06-30 13F Bristol Myers Squibb COM 110122108 5,919 75 1.28 268 -3.94 0.0534
2019-05-14 2019-03-31 13F Bristol Myers Squibb COM 110122108 5,844 -1,200 -17.04 279 -23.77 0.0573
2019-02-13 2018-12-31 13F Bristol Myers Squibb COM 110122108 7,044 -225 -3.10 366 -18.85 0.0815
2018-11-19 2018-09-30 13F Bristol Myers Squibb COM 110122108 7,269 0 0.00 451 12.19 0.0850
2018-08-15 2018-06-30 13F Bristol Myers Squibb COM 110122108 7,269 -124 -1.68 402 -14.10 0.0805
2018-05-14 2018-03-31 13F Bristol Myers Squibb COM 110122108 7,393 1,000 15.64 468 19.39 0.0937
2018-02-14 2017-12-31 13F Bristol Myers Squibb COM 110122108 6,393 0 0.00 392 -3.69 0.0752
2017-11-09 2017-09-30 13F Bristol Myers Squibb COM 110122108 6,393 0 0.00 407 14.33 0.0827
2017-08-16 2017-06-30 13F Bristol Myers Squibb COM 110122108 6,393 -1,000 -13.53 356 -11.44 0.0727
2017-05-12 2017-03-31 13F Bristol Myers Squibb COM 110122108 7,393 2,700 57.53 402 46.72 0.0842
2017-02-28 2016-12-31 13F Bristol Myers Squibb COM 110122108 4,693 0 0.00 274 8.30 0.0596
2016-11-21 2016-09-30 13F Bristol Myers Squibb COM 110122108 4,693 -300 -6.01 253 -31.06 0.0566
2016-08-04 2016-06-30 13F Bristol Myers Squibb COM 110122108 4,993 0 0.00 367 15.05 0.0840
2016-05-13 2016-03-31 13F Bristol Myers Squibb COM 110122108 4,993 50 1.01 319 -6.18 0.0755
2016-02-08 2015-12-31 13F Bristol Myers Squibb COM 110122108 4,943 -100 -1.98 340 13.71 0.0771
2015-11-12 2015-09-30 13F Bristol Myers Squibb COM 110122108 5,043 0 0.00 299 -11.01 0.0698
2015-08-20 2015-06-30 13F Bristol Myers Squibb COM 110122108 5,043 0 0.00 336 3.38 0.0700
2015-11-10 2015-03-31 13F/A-1 Bristol Myers Squibb COM 110122108 5,043 0 0.00 325 9.06 0.0656
2015-05-20 2015-03-31 13F Bristol Myers Squibb COM 110122108 5,043 325
2015-02-17 2014-12-31 13F Bristol Myers Squibb COM 110122108 5,043 0 0.00 298 15.50 0.0595
2014-11-17 2014-09-30 13F Bristol Myers Squibb COM 110122108 5,043 0 0.00 258 5.31 0.0537
2014-08-12 2014-06-30 13F Bristol Myers Squibb COM 110122108 5,043 -739 -12.78 245 -18.33 0.0501
2014-05-14 2014-03-31 13F Bristol Myers Squibb COM 110122108 5,782 0 0.00 300 -2.28 0.0639
2014-02-12 2013-12-31 13F Bristol Myers Squibb COM 110122108 5,782 0 0.00 307 14.55 0.0646
2013-11-12 2013-09-30 13F Bristol Myers Squibb COM 110122108 5,782 0 0.00 268 3.88 0.0620
2013-08-15 2013-06-30 13F Bristol Myers Squibb COM 110122108 5,782 5,782 258 0.0624
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.